Quadrature Capital’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$122K Buy
+19,169
New +$94K ﹤0.01% 1445
2026
Q1
– Sell
-35,583
Closed -$101K – 1361
2025
Q4
$101K Buy
35,583
+25,373
+249% +$131K ﹤0.01% 1102
2025
Q3
$71.1K Buy
+10,210
New +$72K ﹤0.01% 923
2025
Q2
– Sell
-25,300
Closed -$161K – 1041
2025
Q1
$161K Buy
25,300
+10,014
+66% +$96.5K ﹤0.01% 889
2024
Q4
$181K Buy
+15,286
New +$261K ﹤0.01% 858
2024
Q3
– Sell
-10,038
Closed -$239K – 964
2024
Q2
$239K Buy
+10,038
New +$236K ﹤0.01% 896
2023
Q1
– Sell
-16,782
Closed -$198K – 916
2022
Q4
$198K Buy
+16,782
New +$192K 0.01% 727

Other funds holding ASPN

Quadrature Capital's ASPN Position: Q2 2026 in Review

Quadrature Capital opened a new position in Aspen Aerogels (ASPN) in Q2 2026: 19,169 shares worth $122K. The stake represents ﹤0.01% of the portfolio and ranks #1445 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in ASPN as recently as Q4 2025.

Quadrature Capital first reported a position in ASPN in Q4 2022 and has held it in 7 quarters since. The position peaked at $239K in Q2 2024. 179 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.

  • Quadrature Capital held 19,169 shares of Aspen Aerogels worth $122K as of Q2 2026.
  • Aspen Aerogels was a new Quadrature Capital position in Q2 2026.
  • Aspen Aerogels made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1445 holding.
  • Quadrature Capital first reported a position in Aspen Aerogels in Q4 2022 and has held it in 7 quarters since.
  • Quadrature Capital's Aspen Aerogels position peaked at $239K in Q2 2024.
  • 179 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.